This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
Market Access DMCC

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Thrombophilia Testing Market

Market Insights on Thrombophilia Testing covering sales outlook, demand forecast & up-to-date key trends

Thrombophilia Testing Market: Global Industry Analysis 2014 - 2018 and Opportunity Assessment 2019 - 2029

Thrombophilia Testing Market Overview

This Thrombophilia Testing market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study.

This study is one of the most comprehensive documentation that captures all the facets of the evolving Thrombophilia Testing market.

Thrombophilia or hypercoagulability is a condition in which the blood cell coagulation rate increases, leading to thrombosis. It occurs due to abnormalities in blood such as increase in red blood cells (polycythaemia) or increase in platelets (thrombocytosis or thrombocythemia). There are two types of Thrombophilia i.e. Inherited type and Acquired type.

Inherited type of Thrombophilia occur due to abnormalities of the genes which leads the coagulation proteins (known as genetic mutations). The inherited thrombophilia include Factor V Leiden (specific gene), deficiencies of Protein C, Protein S, Prothrombin gene mutations and Prothrombin gene variant 20210A.

The acquired thrombophilia occurs due to abnormal clotting of the blood cells or special proteins which may also lead to clotting. The acquired thrombophilia occurs during surgery, injury, or medical conditions such as congestive heart failure and certain respiratory conditions which are called as Antiphospholipid antibodies.

The coagulation testing are carried out to identify the clots in blood vessel. There are several coagulation tests are carried out for identifying the thrombophilia such as complete blood count, Factor V assay, bleeding time, thrombin time, and platelet count and fibrinogen level. Thrombophilia testing is also used inappropriately to decide about primary or secondary thromboprophylaxis.

Thrombophilia Testing Market: Drivers and Restraints

The advance technologies used for thrombophilia testing and increasing aging population across the world are major drivers for thrombophilia testing market. The various government associations have taken initiatives to raise awareness through events about various blood disorders that may leads to thrombophilia testing.

The poor reimbursement policies provided by government and cost and high cost of treatment in many developing countries across the world are expected to hinder the growth considerably for thrombophilia testing Market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Thrombophilia Testing Market: Overview

The global market for thrombophilia testing is estimated to experience a significant growth during the forecast period. The increase in the aging population, increasing occurrence of rare and chronic diseases will create a more lucrative opportunity for thrombophilia testing in the forecast period. The thrombophilia testing include set of tests such as Factor V Assay, Prothrombin Time (PT or PT-INR).  Fibrinogen Level, Complete Blood Count (CBC), Platelet Count, Thrombin Time, Bleeding Time.

Thrombophilia Testing Market: Regional Wise Outlook

On the basis of geography, the thrombophilia testing market is classified into seven regions viz. South Asia, East Asia, Europe, Latin America, North America, Oceania and Middle East and Africa. The North America and European Union are anticipated the major region for the thrombophilia testing.

East and South Asia Pacific region are developing economically and increasing their investment in healthcare system which may helpful for thrombophilia testing. Advanced or emerging healthcare settings help in restoring the market and increase the reach to a wider section of patients in need.

In North America and Europe region are major reason due to their early adoption of advanced technology, high health care expenditure, increasing government initiatives for research and development activities estimated to have a significant share in the thrombophilia testing market, owing to its quality infrastructure supporting the need of thrombophilia testing.

The market of thrombophilia testing include Siemens Healthineers (Europe), Accriva Diagnostics (U.S.A.), Instrumentation Laboratory (U.S.), HomoSonics LLC. (U.S.), Sienco, Inc. (U.S.), Alere Inc. (U.S.). The present market structure of thrombophilia testing is expected to change with efforts and research present in clinical diagnosis.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Regional analysis of the Thrombophilia Testing market report includes

  • North America
  • Latin America
  • Europe
  • South  Asia
  • East Asia
  • Oceania
  • Middle East and Africa
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Thrombophilia Testing Market: Segmentation

Tentatively, the global thrombophilia testing market has been segmented on the basis of product type, test type, end user and geography.

Based on product type, the global Thrombophilia Testing market is segmented as:

  • Kits and reagents
  • Instruments (HPLC)
  • Automated
  • semi-automated

Based on test type, the global Thrombophilia Testing market is segmented as:

  • Complete Blood Count (CBC)  
  • Factor V Assay
  • Fibrinogen Level  
  • Prothrombin Time (PT or PT-INR)
  • Platelet Count
  • Thrombin Time
  • Bleeding Time

Based on end user, the global Thrombophilia Testing market is segmented as:

  • Hospital
  • Diagnostic laboratories
  • Academic institutions

Table of Content

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Sabyasachi Ghosh
Principal Consultant
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts


Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Thrombophilia Testing Market